168 related articles for article (PubMed ID: 1690915)
1. The influence of FK-506 and low-concentration ciclosporin on human lymphocyte activation antigen expression and blastogenesis: a flow cytometric analysis.
Woo J; Sewell HF; Thomson AW
Scand J Immunol; 1990 Mar; 31(3):297-304. PubMed ID: 1690915
[TBL] [Abstract][Full Text] [Related]
2. Effects of FK 506 and low concentration cyclosporine on human lymphocyte activation antigen expression: a flow cytometric analysis.
Woo J; Sewell HF; Thomson AW
Transplant Proc; 1990 Aug; 22(4):1645-6. PubMed ID: 1697113
[No Abstract] [Full Text] [Related]
3. Effects of combined administration of FK 506 and the purine biosynthesis inhibitors mizoribine or mycophenolic acid on lymphocyte DNA synthesis and T cell activation molecule expression in human mixed lymphocyte cultures.
Thomson AW; Woo J; Yao GZ; Todo S; Starzl TE; Zeevi A
Transpl Immunol; 1993; 1(2):146-50. PubMed ID: 7521738
[TBL] [Abstract][Full Text] [Related]
4. Antigen presentation and HLA-DR expression by FK-506-treated human monocytes.
Woo J; Propper DJ; Thomson AW
Immunology; 1990 Dec; 71(4):551-5. PubMed ID: 1703987
[TBL] [Abstract][Full Text] [Related]
5. Distinct mechanisms of suppression of murine T cell activation by the related macrolides FK-506 and rapamycin.
Dumont FJ; Staruch MJ; Koprak SL; Melino MR; Sigal NH
J Immunol; 1990 Jan; 144(1):251-8. PubMed ID: 1688572
[TBL] [Abstract][Full Text] [Related]
6. Cyclosporin A does not inhibit the PHA-stimulated increase in intracellular Ca2+ concentration but inhibits the increase in E-rosette receptor (CD2) expression and appearance of interleukin-2 receptors (CD25).
Redelman D
Cytometry; 1988 Mar; 9(2):156-63. PubMed ID: 2896111
[TBL] [Abstract][Full Text] [Related]
7. The immunosuppressive macrolides FK-506 and rapamycin act as reciprocal antagonists in murine T cells.
Dumont FJ; Melino MR; Staruch MJ; Koprak SL; Fischer PA; Sigal NH
J Immunol; 1990 Feb; 144(4):1418-24. PubMed ID: 1689353
[TBL] [Abstract][Full Text] [Related]
8. FK-506 and cyclosporin A inhibit highly similar signal transduction pathways in human T lymphocytes.
Lin CS; Boltz RC; Siekierka JJ; Sigal NH
Cell Immunol; 1991 Apr; 133(2):269-84. PubMed ID: 1707760
[TBL] [Abstract][Full Text] [Related]
9. Evidence that the immunosuppressive effects of FK506 and cyclosporine are identical.
Johansson A; Möller E
Transplantation; 1990 Dec; 50(6):1001-7. PubMed ID: 1701570
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of T-lymphocyte activation by the immunosuppressive drug FK-506.
Kay JE; Benzie CR; Goodier MR; Wick CJ; Doe SE
Immunology; 1989 Aug; 67(4):473-7. PubMed ID: 2475433
[TBL] [Abstract][Full Text] [Related]
11. The effect of the immunosuppressant FK-506 on alternate pathways of T cell activation.
Bierer BE; Schreiber SL; Burakoff SJ
Eur J Immunol; 1991 Feb; 21(2):439-45. PubMed ID: 1705513
[TBL] [Abstract][Full Text] [Related]
12. Cyclosporine inhibits the expression of receptors for interleukin 2 and transferrin on mitogen-activated human T lymphocytes.
Prince HE; John JK
Immunol Invest; 1986 Aug; 15(5):463-72. PubMed ID: 3096881
[TBL] [Abstract][Full Text] [Related]
13. Synergistic and antagonistic effects of combinations of cyclosporine A and its metabolites on inhibition of phytohemagglutinin-induced lymphocyte transformation in vitro.
Schultz JC; Lensmeyer GL; Wendal TD; Shahidi NT; Wiebe DA; Carlson IH
Biochem Pharmacol; 1991 Sep; 42(7):1403-10. PubMed ID: 1834063
[TBL] [Abstract][Full Text] [Related]
14. Effect of FK-506 and cyclosporine on human T and B lymphoproliferative responses.
Wasik M; Stepień-Sopniewska B; Lagodziński Z; Górski A
Immunopharmacology; 1990; 20(1):57-61. PubMed ID: 1699911
[TBL] [Abstract][Full Text] [Related]
15. Effect of a new immunosuppressive agent, FK506, on human lymphocyte responses in vitro. I. Inhibition of expression of alloantigen-activated suppressor cells, as well as induction of alloreactivity.
Yoshimura N; Matsui S; Hamashima T; Oka T
Transplantation; 1989 Feb; 47(2):351-6. PubMed ID: 2465592
[TBL] [Abstract][Full Text] [Related]
16. Anti-CD3 antibody-induced expression of both p55 and p75 chains of the high affinity interleukin-2 receptor on human T lymphocytes is inhibited by cyclosporin A.
Foxwell BM; Simon J; Herrero JJ; Taylor D; Woerly G; Cantrell D; Ryffel B
Immunology; 1990 Jan; 69(1):104-9. PubMed ID: 2312149
[TBL] [Abstract][Full Text] [Related]
17. Cytofluorimetric analysis of mitogen-activated peripheral blood lymphocytes of non-leukemic lymphoma patients reveals an abnormal disease-related expression pattern of activation antigens.
Mangge H; Beaufort F; Kaulfersch W; Rossipal E; Schauenstein K
J Cancer Res Clin Oncol; 1990; 116(6):575-80. PubMed ID: 2174895
[TBL] [Abstract][Full Text] [Related]
18. FK-506, a potent novel inhibitor of the release of proinflammatory mediators from human Fc epsilon RI+ cells.
de Paulis A; Cirillo R; Ciccarelli A; Condorelli M; Marone G
J Immunol; 1991 Apr; 146(7):2374-81. PubMed ID: 1706398
[TBL] [Abstract][Full Text] [Related]
19. Comparison of the effects of FK-506, cyclosporin A and rapamycin on IL-2 production.
Henderson DJ; Naya I; Bundick RV; Smith GM; Schmidt JA
Immunology; 1991 Jul; 73(3):316-21. PubMed ID: 1715317
[TBL] [Abstract][Full Text] [Related]
20. Mixed lymphocyte reaction-induced release of soluble IL-2 receptor.
Degiannis D; Czarnecki M; Hornung N; Raskova J; Raska K
Transplantation; 1991 Feb; 51(2):518-23. PubMed ID: 1825248
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
